Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-11

Clinical Trial Update: Clinical Outcome of Vinpocetine in Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 2/Phase 3 study of vinpocetine for diabetic kidney disease/diabetic nephropathy, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinpocetine (vinpocetine)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetic Kidney Disease, Diabetic Nephropathies | Phase 2, Phase 3 | Status: RECRUITING